Comparative Estimation of ROS Levels using DCFDA in Zebrafish Larvae Model on the Treatment of Camphene and Doxorubicin for Antioxidant Property

To assess the impact of Camphene and Doxorubicin on ROS levels in Zebrafish larvae, the study induced oxidative stress using 1 mM H2O2. DCFDA enzymatic assay was utilised to detect intracellular ROS levels in the zebrafish larvae. The compounds were prepared into a solution by diluting the stock sol...

Full description

Bibliographic Details
Main Authors: Timothy R., Praveen Kumar I.
Format: Article
Language:English
Published: EDP Sciences 2024-01-01
Series:E3S Web of Conferences
Subjects:
Online Access:https://www.e3s-conferences.org/articles/e3sconf/pdf/2024/07/e3sconf_star2024_00050.pdf
_version_ 1827371899468906496
author Timothy R.
Praveen Kumar I.
author_facet Timothy R.
Praveen Kumar I.
author_sort Timothy R.
collection DOAJ
description To assess the impact of Camphene and Doxorubicin on ROS levels in Zebrafish larvae, the study induced oxidative stress using 1 mM H2O2. DCFDA enzymatic assay was utilised to detect intracellular ROS levels in the zebrafish larvae. The compounds were prepared into a solution by diluting the stock solution with DMSO. Zebrafish were bred in a spawning tank at a 1:1 female-to-male ratio, and their eggs were collected, segregated into four petri plates, and exposed to Camphene from 4 hours post fertilization (hpf) until 96hpf. The hatching and mortality rates were monitored at 96hpf, calculated as the ratio of hatched larvae to the total number of live larvae at observation. Statistical analysis was conducted using SPSS software with preset parameters (threshold of 0.05, 80% G power, sample size n=15, 95% confidence interval, and an enrolment ratio of 1). The study revealed significant differences (p=0.000, p<0.05) between the compound-exposed embryos (62.4667±1.88) and the control group (34.4000±0.07). Early exposure to Camphene at 26 μmol demonstrated a positive impact on the antioxidant capacity in zebrafish larvae, as indicated by fluorescence intensity. This suggests that Camphene treatment effectively counteracts H2O2-induced ROS production in zebrafish larvae. Specifically, fluorescence intensity was 30% lower in the Camphene-exposed group compared to the Doxorubicin-exposed group.
first_indexed 2024-03-08T10:48:27Z
format Article
id doaj.art-845f5dff74974148a4efa25cc6c5691c
institution Directory Open Access Journal
issn 2267-1242
language English
last_indexed 2024-03-08T10:48:27Z
publishDate 2024-01-01
publisher EDP Sciences
record_format Article
series E3S Web of Conferences
spelling doaj.art-845f5dff74974148a4efa25cc6c5691c2024-01-26T16:52:14ZengEDP SciencesE3S Web of Conferences2267-12422024-01-014770005010.1051/e3sconf/202447700050e3sconf_star2024_00050Comparative Estimation of ROS Levels using DCFDA in Zebrafish Larvae Model on the Treatment of Camphene and Doxorubicin for Antioxidant PropertyTimothy R.0Praveen Kumar I.1Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha UniversityDepartment of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha UniversityTo assess the impact of Camphene and Doxorubicin on ROS levels in Zebrafish larvae, the study induced oxidative stress using 1 mM H2O2. DCFDA enzymatic assay was utilised to detect intracellular ROS levels in the zebrafish larvae. The compounds were prepared into a solution by diluting the stock solution with DMSO. Zebrafish were bred in a spawning tank at a 1:1 female-to-male ratio, and their eggs were collected, segregated into four petri plates, and exposed to Camphene from 4 hours post fertilization (hpf) until 96hpf. The hatching and mortality rates were monitored at 96hpf, calculated as the ratio of hatched larvae to the total number of live larvae at observation. Statistical analysis was conducted using SPSS software with preset parameters (threshold of 0.05, 80% G power, sample size n=15, 95% confidence interval, and an enrolment ratio of 1). The study revealed significant differences (p=0.000, p<0.05) between the compound-exposed embryos (62.4667±1.88) and the control group (34.4000±0.07). Early exposure to Camphene at 26 μmol demonstrated a positive impact on the antioxidant capacity in zebrafish larvae, as indicated by fluorescence intensity. This suggests that Camphene treatment effectively counteracts H2O2-induced ROS production in zebrafish larvae. Specifically, fluorescence intensity was 30% lower in the Camphene-exposed group compared to the Doxorubicin-exposed group.https://www.e3s-conferences.org/articles/e3sconf/pdf/2024/07/e3sconf_star2024_00050.pdfinnovative zebrafish modelcamphenezebrafish larvaeros leveldoxorubicintoxicitymortality rate
spellingShingle Timothy R.
Praveen Kumar I.
Comparative Estimation of ROS Levels using DCFDA in Zebrafish Larvae Model on the Treatment of Camphene and Doxorubicin for Antioxidant Property
E3S Web of Conferences
innovative zebrafish model
camphene
zebrafish larvae
ros level
doxorubicin
toxicity
mortality rate
title Comparative Estimation of ROS Levels using DCFDA in Zebrafish Larvae Model on the Treatment of Camphene and Doxorubicin for Antioxidant Property
title_full Comparative Estimation of ROS Levels using DCFDA in Zebrafish Larvae Model on the Treatment of Camphene and Doxorubicin for Antioxidant Property
title_fullStr Comparative Estimation of ROS Levels using DCFDA in Zebrafish Larvae Model on the Treatment of Camphene and Doxorubicin for Antioxidant Property
title_full_unstemmed Comparative Estimation of ROS Levels using DCFDA in Zebrafish Larvae Model on the Treatment of Camphene and Doxorubicin for Antioxidant Property
title_short Comparative Estimation of ROS Levels using DCFDA in Zebrafish Larvae Model on the Treatment of Camphene and Doxorubicin for Antioxidant Property
title_sort comparative estimation of ros levels using dcfda in zebrafish larvae model on the treatment of camphene and doxorubicin for antioxidant property
topic innovative zebrafish model
camphene
zebrafish larvae
ros level
doxorubicin
toxicity
mortality rate
url https://www.e3s-conferences.org/articles/e3sconf/pdf/2024/07/e3sconf_star2024_00050.pdf
work_keys_str_mv AT timothyr comparativeestimationofroslevelsusingdcfdainzebrafishlarvaemodelonthetreatmentofcampheneanddoxorubicinforantioxidantproperty
AT praveenkumari comparativeestimationofroslevelsusingdcfdainzebrafishlarvaemodelonthetreatmentofcampheneanddoxorubicinforantioxidantproperty